Invasight

BiotechnologySeedZurich, Switzerlandinvasight.com

Latest round

Seed

Last raised

Jun 2022

Total raised

$4.5M

Investors

7

About Invasight

Based in Zurich, Switzerland, founded in 2019 by Karthiga Kumar and Sam Fulcher, Invasight AG operates as a biotechnology company that specializes in accelerating drug discovery and facilitating the development of targeted opponents for intercellular protein interactions that are rarely addressed in cancer research. Invasight AG is a biotech company that develops to treat cancer in the early stage. The company's operations include advancing drug discovery and facilitating the development of targeted antagonists for non-traditionally targeted intercellular protein interactions (known as PPIAs). The company hopes to make a significant difference in the lives of patients by focusing on these specific protein targets that contribute to cancer cell invasion.

Who invested in Invasight

7 investors across 1 round

See all investors in Invasight

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jun 7, 2022

    Amount

    $4.5M

    Investors

    Locked

Questions about Invasight

Who invested in Invasight?

Invasight has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Invasight raised?

Invasight has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Invasight last raise money?

Invasight's most recent round on record is a Seed, in Jun 2022.

What does Invasight do?

Based in Zurich, Switzerland, founded in 2019 by Karthiga Kumar and Sam Fulcher, Invasight AG operates as a biotechnology company that specializes in accelerating drug discovery and facilitating the development of targeted opponents for intercellular protein interactions that are rarely addressed in cancer research.

Where is Invasight headquartered?

Invasight is headquartered in Zurich, Switzerland.

Which VCs invest in companies like Invasight?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Invasight's stage. Their profiles are linked below.

Raising like Invasight? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.